Should You Buy Moderna Right Now?
Has (NASDAQ: MRNA) finally bottomed out? You may be asking that yourself right now, as shares in the biotech company have held steady at around $25 per share over the past six months.
Moderna might be a shell of its former self, no longer making billions from its COVID-19 vaccine, but it's still sitting on billions of dollars in capital. The company also has many promising candidates in its drug development pipeline.
Image source: Getty Images.
Source Fool.com
Moderna Inc. Stock
€54.98
0.480%
Our community is currently high on Moderna Inc. with 11 Buy predictions and 8 Sell predictions.
On the other hand, the target price of 21 € is below the current price of 54.98 € for Moderna Inc., so the potential is actually -61.8%.


